Researchers in the academic environment preferred generating antibodies in-house by making use of the animal facilities in their faculties. The best chance of success is to try an antibody that already was confirmed to perform correctly in the required platform.īased on feedback from about 10 years ago, scepticism and mistrust towards commercial antibodies was already commonplace. In addition, one cannot assume that every antibody is fit for every application. Antibodies can be found with Quality Control data obtained from previous batches that no longer represent the batch on sale. Antibodies endorsed by scientific research papers do not always meet the scientist’s requirements either due to flawed specifications, or due to batch-to-batch variations. Lots of money goes to waste in buying and trying one failing antibody after the other without realizing all the pitfalls that come with the product: Antibodies can get inactivated, both the biological material and the assay itself can potentially be flawed, a single antibody featuring in many different catalogues can be deemed as a set of different products, and a bad choice of antibody type, wrong dilutions, and lack of proper validation can all jeopardize the intended experiments. A variety of issues, each one potentially causing an antibody to fail, underpin the frustrations that scientists endure. Despite an impressive growth in the business of research antibodies a general lack of trust in commercial antibodies remains in place.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |